Vistagen Therapeutics Inc (VTGN)
2.53
-0.08
(-3.07%)
USD |
NASDAQ |
Nov 21, 16:00
2.54
+0.01
(+0.40%)
After-Hours: 20:00
Vistagen Therapeutics Profit Margin (Quarterly): -7.08K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -7.08K% |
| June 30, 2024 | -12.78K% |
| March 31, 2024 | -4.83K% |
| December 31, 2023 | -1.54K% |
| September 30, 2023 | -2.37K% |
| June 30, 2023 | -3.90K% |
| March 31, 2023 | -6.95K% |
| December 31, 2022 | -5.43K% |
| September 30, 2022 | |
| June 30, 2022 | -6.38K% |
| March 31, 2022 | -42.90K% |
| December 31, 2021 | -2.94K% |
| September 30, 2021 | -3.57K% |
| June 30, 2021 | -2.19K% |
| March 31, 2021 | -1.41K% |
| December 31, 2020 | -1.69K% |
| September 30, 2020 | -987.4% |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -211.1% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | -911.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-42.90K%
Minimum
Mar 2022
-987.4%
Maximum
Sep 2020
-6.68K%
Average
-3.74K%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -42.00% |
| Return on Assets | -38.57% |
| Return on Invested Capital | -42.00% |
| Operating Margin (Quarterly) | -7.77K% |
| Return on Net Operating Assets | -1.74K% |